Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)

CAPS Rating: 3 out of 5

A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer.

Recs

0
Player Avatar irishred1 (< 20) Submitted: 5/8/2012 1:34:50 PM : Outperform Start Price: $5.97 THLD Score: +22.99

still promising as ever- eurozone bringin it down makes lots of sense...NOT

Member Avatar irishred1 (< 20) Submitted: 6/11/2012 8:53:52 AM
Recs: 0

http://seekingalpha.com/article/649941-threshold-s-management-presents-at-jefferies-healthcare-conference-notes

was gonna close this one, but more bullish on it than ever now long term

Featured Broker Partners


Advertisement